Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cisco
CSCO
$470B
| $824M | 1.02% |
20,969,492
-9,397,997
| -31% | -$412M |
|
27
iShares MBS ETF
MBB
$39.1B
| $781M | 0.97% |
7,071,609
+258,478
| +4% | +$28.1M |
|
28
Sanofi
SNY
$105B
| $772M | 0.96% |
17,662,027
+114,682
| +0.7% | +$5.49M |
|
29
TotalEnergies
TTE
$181B
| $748M | 0.93% |
20,095,125
+291,537
| +1% | +$13.1M |
|
30
AstraZeneca
AZN
$263B
| $739M | 0.92% |
8,278,287
+92,933
| +1% | +$8.75M |
|
31
Novartis
NVS
$293B
| $704M | 0.87% |
8,534,868
+113,098
| +1% | +$10.1M |
|
32
Merck
MRK
$306B
| $685M | 0.85% |
9,335,072
+18,316
| +0.2% | +$1.44M |
|
33
PayPal
PYPL
$42B
| $671M | 0.83% |
7,003,347
+2,775,699
| +66% | +$306M |
|
34
Caterpillar
CAT
$429B
| $651M | 0.81% |
5,609,147
+62,036
| +1% | +$7.92M |
|
|
35
Meta Platforms (Facebook)
META
$1.67T
| $643M | 0.8% |
3,852,395
+3,542,165
| +1,142% | +$693M |
|
36
Oracle
ORCL
$379B
| $638M | 0.79% |
13,209,055
-2,754,898
| -17% | -$142M |
|
|
FIYY
37
DELISTED
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
| $628M | 0.78% |
9,680,548
-226,485
| -2% | -$23.3M |
|
38
Eli Lilly
LLY
$1.05T
| $601M | 0.75% |
4,334,447
-77,563
| -2% | -$10.7M |
|
39
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $596M | 0.74% |
19,699,477
-161,703
| -0.8% | -$4.94M |
|
40
GSK
GSK
$105B
| $589M | 0.73% |
12,431,972
+101,603
| +0.8% | +$5.42M |
|
|
SI
41
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $549M | 0.68% |
12,909,979
+61,159
| +0.5% | +$2.6M |
|
42
JPMorgan Chase
JPM
$896B
| $544M | 0.67% |
6,039,705
+80,640
| +1% | +$9.8M |
|
43
Union Pacific
UNP
$172B
| $528M | 0.66% |
3,746,433
+1,897,913
| +103% | +$314M |
|
|
RDS.A
44
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $520M | 0.64% |
14,896,649
+371,868
| +3% | +$17.4M |
|
45
Rio Tinto
RIO
$146B
| $508M | 0.63% |
11,140,243
+123,742
| +1% | +$6.35M |
|
|
46
Nike
NKE
$64.8B
| $488M | 0.6% |
5,892,758
+5,862,137
| +19,144% | +$545M |
|
47
RTX Corp
RTX
$264B
| $454M | 0.56% |
7,645,397
+69,890
| +0.9% | +$5.91M |
|
|
48
Walt Disney
DIS
$167B
| $435M | 0.54% |
4,504,570
+4,423,621
| +5,465% | +$559M |
|
49
Chevron
CVX
$363B
| $369M | 0.46% |
5,096,800
-83,143
| -2% | -$8.22M |
|
50
Intuitive Surgical
ISRG
$144B
| $350M | 0.43% |
2,120,793
+1,920,003
| +956% | +$352M |
|
Similar funds
